The article by Chen and Halpern1 presents a good way of assessing the actual outcome of laryngeal cancer in a population following treatment modifications adopted based on level I evidence from clinical trials. The study actually looked at the outcome in a large sample of patients with laryngeal cancer over a long follow-up period. However, we have 2 reservations regardng the way the analysis was performed and the conclusions that were drawn from the analysis.